Literature DB >> 10256918

Patient behavior patterns regarding prescription refills.

R M Schulz, J P Gagnon.   

Abstract

This study was conducted to examine the association between drug price, drug category, duration of coverage of the original prescription, units prescribed per day, and a patient's failure to obtain authorized refills of prescription medication. A two-stage sampling of pharmacies and prescriptions yielded a total sample of 1,058 prescriptions. The Drug Possession Ratio (DPR), defined as the ratio of number of days of medication dispensed to number of days of medication prescribed, was significantly related to drug price and drug category (p less than 0.05). The highest DPR was associated with the most expensive medication. Tranquilizers, antidepressants, and sedative hypnotics exhibited high DPR, while antihistamines and decongestants exhibited low DPR.

Entities:  

Mesh:

Year:  1982        PMID: 10256918

Source DB:  PubMed          Journal:  Contemp Pharm Pract        ISSN: 0162-3761


  4 in total

1.  Medication, quality of life and compliance: the role of the pharmacist.

Authors:  M Smith
Journal:  Pharmacoeconomics       Date:  1992-04       Impact factor: 4.981

2.  Antipsychotic treatment patterns and hospitalizations among adults with schizophrenia.

Authors:  Susan dosReis; Elizabeth Johnson; Donald Steinwachs; Charles Rohde; Elizabeth A Skinner; Maureen Fahey; Anthony F Lehman
Journal:  Schizophr Res       Date:  2008-02-05       Impact factor: 4.939

3.  Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases.

Authors:  Margret V Bjarnadottir; David Czerwinski; Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2018-03       Impact factor: 4.981

4.  Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study.

Authors:  Wenxin Xu; Saveli I Goldberg; Maria Shubina; Alexander Turchin
Journal:  BMJ       Date:  2015-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.